Literature DB >> 19903004

Using stem cells to mend the retina in ocular disease.

Natalie D Bull1, Keith R Martin.   

Abstract

Retinal degenerative diseases are the leading cause of incurable blindness worldwide. Furthermore, existing pharmacological and surgical interventions are only partially effective in halting disease progression, thus adjunctive neuroprotective strategies are desperately needed to preserve vision. Stem cells appear to possess inherent neuroprotective abilities, at least in part by providing neurotrophic support to injured neurons. Advances in stem cell biology offer the hope of new therapies for a broad range of neurodegenerative conditions, including those of the retina. Experimental cell-mediated therapies also hint at the tantalizing possibility of achieving retinal neuronal replacement and regeneration, once cells are lost to the disease process. This article summarizes the latest advances in cell therapies for neuroprotection and regeneration in neurodegenerative pathologies of both the inner and outer retina.

Entities:  

Mesh:

Year:  2009        PMID: 19903004     DOI: 10.2217/rme.09.59

Source DB:  PubMed          Journal:  Regen Med        ISSN: 1746-0751            Impact factor:   3.806


  7 in total

1.  Differentiation of induced pluripotent stem cells of swine into rod photoreceptors and their integration into the retina.

Authors:  Liang Zhou; Wei Wang; Yongqing Liu; Juan Fernandez de Castro; Toshihiko Ezashi; Bhanu Prakash V L Telugu; R Michael Roberts; Henry J Kaplan; Douglas C Dean
Journal:  Stem Cells       Date:  2011-06       Impact factor: 6.277

2.  Biocompatibility of intravitreal injection of human mesenchymal stem cells in immunocompetent rabbits.

Authors:  Sonia Labrador Velandia; Salvatore Di Lauro; Maria Luz Alonso-Alonso; Soraya Tabera Bartolomé; Girish Kumar Srivastava; José Carlos Pastor; Ivan Fernandez-Bueno
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-22       Impact factor: 3.117

3.  Stem cell therapy for glaucoma: possibilities and practicalities.

Authors:  Thomas V Johnson; Natalie D Bull; Keith R Martin
Journal:  Expert Rev Ophthalmol       Date:  2011-04-01

4.  Endogenously EGFP-Labeled Mouse Embryonic Stem Cells.

Authors:  Junli Zhang; Rammohan V Rao; Patricia Spilman; Julie Mangada; Lin Xie; Cathy Vitelli; Olivia F Gorostiza; David T Madden; Xianmin Zeng; Kunlin Jin; Matthew J Hart; Dale E Bredesen; Veronica Galvan
Journal:  Aging Dis       Date:  2011-02       Impact factor: 6.745

5.  Behavior of Transplanted Multipotent Cells after in Vitro Transplantation into the Damaged Retina.

Authors:  S A Sergeev; Y V Khramova; M L Semenova; I N Saburina; N V Kosheleva
Journal:  Acta Naturae       Date:  2011-10       Impact factor: 1.845

6.  Atoh7 promotes the differentiation of retinal stem cells derived from Müller cells into retinal ganglion cells by inhibiting Notch signaling.

Authors:  Wei-tao Song; Xue-yong Zhang; Xiao-bo Xia
Journal:  Stem Cell Res Ther       Date:  2013-08-14       Impact factor: 6.832

Review 7.  Current perspective of neuroprotection and glaucoma.

Authors:  Kailin Tian; Shannon Shibata-Germanos; Milena Pahlitzsch; M Francesca Cordeiro
Journal:  Clin Ophthalmol       Date:  2015-11-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.